Lifecome Biochemistry Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Net Income	-139.26	-444.86	-221.82	-121.94	-26.04
Depreciation & Amortization	97.85	100.24	71.06	64.17	33.94
Other Amortization	2.88	1.57	0.07	0.19	0.03
Loss (Gain) From Sale of Assets	-0.27	-0.04	0.04	-0	-0.01
Asset Writedown & Restructuring Costs	3.04	171.99	24.86	6.25	0.22
Loss (Gain) From Sale of Investments	-4.55	-9.25	-11.43	10.12	20.56
Provision & Write-off of Bad Debts	-1.55	0.38	1.27	1.35	0.72
Other Operating Activities	73.7	115.62	96.17	54.62	10.75
Change in Accounts Receivable	22.59	47.21	-51.58	-3.78	-17.23
Change in Inventory	-25.82	53.82	-97.39	-73.51	-15.42
Change in Accounts Payable	-54.16	56.32	15.66	61.29	34.49
Change in Other Net Operating Assets	1.54	30	4.61	3.79	-0.86
Operating Cash Flow	-25.08	141.41	-186.76	-8.83	35.17
Operating Cash Flow Growth	-	-	-	-	-61.23%
Capital Expenditures	-129.8	-125.06	-464.54	-137.32	-357.17
Sale of Property, Plant & Equipment	3.8	0.49	4.93	0.02	4.24
Cash Acquisitions	-	-	-90.89	-	-
Divestitures	-3.63	27.28	294.94	-	-
Other Investing Activities	1.13	7.46	1.31	0.44	-2.09
Investing Cash Flow	-135.26	-89.82	-254.25	-136.86	-355.01
Long-Term Debt Issued	1,148	807.58	910.8	364.79	292.89
Long-Term Debt Repaid	-907.25	-838.33	-454.83	-281.03	-42.5
Net Debt Issued (Repaid)	240.32	-30.76	455.97	83.75	250.39
Issuance of Common Stock	3.37	-	35.7	-	-
Repurchase of Common Stock	-5.72	-	-	-	-
Common Dividends Paid	-42.52	-48.83	-24.22	-12.99	-26.53
Financing Cash Flow	195.44	-79.58	467.45	70.76	223.87
Foreign Exchange Rate Adjustments	-1	-2.71	-0.02	3.19	-0.8
Net Cash Flow	34.1	-30.71	26.43	-71.73	-96.77
Free Cash Flow	-154.88	16.35	-651.3	-146.15	-322
Free Cash Flow Margin	-29.98%	2.52%	-128.46%	-44.31%	-88.61%
Free Cash Flow Per Share	-1.00	0.10	-4.23	-0.95	-2.10
Cash Income Tax Paid	-4.14	-33.58	-28.32	-46.96	-31.32
Levered Free Cash Flow	-415.6	21.82	-231.91	-464.01	-258.76
Unlevered Free Cash Flow	-381.97	60.61	-208.72	-453.87	-257
Change in Working Capital	-56.9	205.76	-146.97	-23.59	-5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.